For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer Cadogan Petroleum
of existing shares to which voting rights are Plc
attached:ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the Pierre Salik
notification obligation:iii
4. Full name of shareholder(s) Same as 3
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or 22/12/2011
reached: v
6. Date on which issuer notified: 5/01/2012
7. Threshold(s) that is/are crossed or 4%
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/ Situation previous Resulting situation after the triggering transaction
type of to the triggering
shares transaction
if Number Number Number Number of voting % of voting
possible of of of shares rights rights x
using Shares Voting
the ISIN Rights
CODE Indirect
Direct Direct xi xii Direct Indirect
Shares
voting
rights 5940000 5940000 11290000 11290000 4.89%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting % of voting
financial date xiii Conversion Period xiv rights that may be rights
instrument acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting rights % of voting
financial price date xvii Conversion instrument refers to rights xix, xx
instrument period
xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
11,290,000 4.89%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name: Stefan Bort
0207 487 8301
15. Contact telephone number:
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.